Last week , ATAGI very carefully considered the latest vaccination findings out of Europe and the UK – which followed extremely rare instances of people, having taken the AstraZeneca vaccine, developing a very specific syndrome involving blood clots with low platelet counts.The syndrome is called “thrombosis with thrombocytopenia”.Based on these updated medical findings out of Europe and the UK, ATAGI recommended some additional precautions for the ongoing use of the AstraZeneca vaccine.ATAGI recommended a preference that the COVID-19 Pfizer vaccine be dispensed to adults under the age of 50 instead of the AstraZeneca vaccine.That recommendation was based on the increasing risk of severe outcomes from COVID-19 in older adults – and hence a.